Hormone therapy, calcium may lower fracture risk
She was biologically male but “self-identified as female throughout her adult life,” according to court documents. “Because of this, she wanted to initiate the gender transition process prior to her incarceration, but found herself unable to do so in the face of the restrictions imposed on her by a conservative family and workplace,” the lawsuit continues. Adams had been diagnosed with gender identity disorder; Manning has also received the same diagnosis. Adams filed a lawsuit in 2009 after her prison denied treatment.
For the original version including any supplementary images or video, visit http://www.washingtonpost.com/blogs/wonkblog/wp/2013/08/22/manning-wants-hormone-therapy-in-prison-will-it-happen/
“We always tell women to take calcium and vitamin D,” said Dr. Michele Curtis, a women’s health researcher from the University of Texas Health Science Center at Houston. “At the end of the day what this study really says is, what you thought was a good thing to do really is a good thing to do.” Because of the known risks of hormone therapy, one of the study’s authors said women should not take it solely to ward off fractures – but if they’re taking hormones for other reasons, it might be a good idea to add calcium. Although many women take calcium and vitamin D for bone health, evidence has been mixed on how much supplements really help over and above what women get through their diets. In February, the government-backed U.S.
For the original version including any supplementary images or video, visit http://www.reuters.com/article/2013/06/28/us-hormone-therapy-idUSBRE95R0YN20130628
Hormone Therapy Linked to Higher Breast Cancer Death Risk
null “It is early in the follow-up and the number of breast cancer deaths will certainly substantially increase as we move forward,” said Dr. Rowan Chlebowski, professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles, and lead author of the study. Women in the study who used estrogen and progestin for five-and-a-half years — which is considered long-term use of the therapy — were at higher risk of getting breast cancer, said Chlebowksi. Earlier results of this trial indicated a connection between synthetic hormone therapy — commonly marketed as as the drug Prempro — and less aggressive forms of breast cancer .
For the original version including any supplementary images or video, visit http://abcnews.go.com/Health/OnCallPlusBreastCancerNews/combination-hormone-therapy-linked-breast-cancer-death/story?id=11920352